Editas Medicine (EDIT) PT Lowered to $9 at Barclays

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

May 9, 2024 2:55 AM EDT
Get Alerts EDIT Hot Sheet
Price: $3.23 +4.87%

Rating Summary:
    12 Buy, 13 Hold, 3 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Barclays analyst Gena Wang lowered the price target on Editas Medicine (NASDAQ: EDIT) to $9.00 (from $11.00) while maintaining a Equalweight rating.

You May Also Be Interested In





Related Categories

Analyst PT Change